J. Michael  Gonzalez-Campoy MD, PhD, FACE's portrait

J. Michael Gonzalez-Campoy MD, PhD, FACE

Medical Director and Chief Executive Officer
Minnesota Center for Obesity, Metabolism, and Endocrinology
Eagan, MN
Dr. Gonzalez-Campoy is a member of the EndocrineWeb Editorial Board.
He is a Senior Editor and oversees the obesity section on EndocrineWeb.

About J. Michael Gonzalez-Campoy MD, PhD, FACE

J. Michael Gonzalez-Campoy, MD, PhD, FACE is Medical Director and Chief Executive Officer of the Minnesota Center for Obesity, Metabolism and Endocrinology in Eagan, Minnesota.

Dr. Gonzalez-Campoy earned his medical degree and PhD in physiology and biophysics from the Mayo Medical School and Mayo Graduate School in Rochester, Minnesota. He received a fellowship in diabetes, endocrinology, and metabolism from the University of Minnesota. His clinical and research interests include the prevention and treatment of obesity and adiposopathy, and their complications.

Dr. Gonzalez-Campoy lectures nationally and internationally and has chaired or been an invited speaker for several national meetings on obesity and adiposopathy. He is past member of the American College of Endocrinology Board of Trustees and the American Association of Clinical Endocrinologists Board of Directors. Dr. Gonzalez supported the launch of the Association of Clinical Researchers and Educators (ACRE), which is dedicated to highlight the value of collaborative relationships between physicians and industry.

Publications

National Diabetes Education Program (NDEP). Guiding Principles for Diabetes Care: For Health Care Professionals. NIH Publication No. 09-4343 NDEP-16. Revised April 2009.

Bays HE, Gonzalez-Campoy JM, Henry RR, Bergman DA. Kitabchi AE, Schorr AB. Rodbard HW. The Adiposopathy Working Group. Is adiposopathy (sick fat) an endocrine disease? Int J Clin Pract. 2008;62(10):1474-83. Epub 2008 Aug 4.

Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Guven S, Spitz AF, Apovian CM, Livingston EH, Brolin R, Sarwer DB, Anderson WA, and Dixon J. Executive Summary Of The Recommendations Of The American Association Of Clinical Endocrinologists, The Obesity Society, And American Society For Metabolic & Bariatric Surgery Medical Guidelines For Clinical Practice For The Perioperative Nutritional, Metabolic, And Nonsurgical Support Of The Bariatric Surgery Patient. Endocr Pract. 2008;14(3):318-36.  

Bays HE, Gonzalez-Campoy JM, Bray GA, Kitabchi AE, Bergman DA, Schorr AB, Rodbard HW, and Henry RR. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther. 2008;6(3): 343-368.  

Kelly AS, Thelen AM, Kaiser DR, Gonzalez-Campoy JM, and Bank AJ. Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus. Vascular Medicine. 2007;12:311–318.

Bank AJ, Kelly AS, Thelen AM, Kaiser DR, Gonzalez-Campoy JM. The effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Hypertens. 2007;20(7):777-83.

Minnesota Medical Association Obesity Task Force. How to Evaluate and Treat Obesity. Minnesota Medicine. 2005;88:40-46.

The Report of the Minnesota Medical Association Health Care Reform Task Force. Minnesota Medicine. 2005;88:Supplement.

Gonzalez-Campoy RC, Gonzalez-Campoy JM. Minnesota Diabetes Plan 2010. Minnesota Medicine. 2003;86:44-48.

Minnesota Diabetes Plan 2010. Recommendations from Minnesota’s Diabetes Community. Facilitated by the Minnesota Department of Health. September, 2003. www.health.state.mn.us/diabetes/2010plan

Hensrud D, Billington C, Blum HT, Gonzalez-Campoy JM, Ramsey S. ICSI Technology Assessment: Pharmacological Approaches to Weight Loss in Adults. 2003. http://www.icsi.org/knowledge/detail.asp?catID=107&itemID=785

Gonzalez-Campoy JM, Long C, Roberts D, Berndt T, Romero JC, Knox FG. Renal interstitial hydrostatic pressure and PGE2 in pressure natriuresis. Am J Physiol (Fluid Electrolyte Metabolism). 1991;260(5):F643-F649.

Gonzalez-Campoy JM, Awazu M, Granger JP, Haas JA, Romero JC, Knox FG. Blunted Pressure Natriuresis in the Brattleboro Diabetes Insipidus Rat. Hypertension. 1989;13:322-326.

Gonzalez-Campoy JM, Kachelski J, Burnett, Jr. JC, Granger JP, Romero JC, Knox FG. Proximal Tubule Response in Aldosterone Escape. Am J Physiol (Regulatory Integrative Comp. Physiol). 1989;256(1):R86-R90.

Chiou RK, Vessella RL, Elson MK, Clayman RV, Gonzalez-Campoy JM, Klicka MJ, Shafer RB, Lange PH. Localization of human renal cell carcinoma xenografts with a tumor-preferential monoclonal antibody.  Cancer Research. 1985;45:6140-6146.

Gonzalez-Campoy JM. Temporal and regional characteristics of cerebral vascular responses to sympathetic nerve stimulation. Abbreviated Reports by Research Participants in the Secondary Student Training Program. 1978;2:73-75, University of Iowa, Iowa City, Iowa.

Articles Written by J. Michael Gonzalez-Campoy MD, PhD, FACE

Care After Bariatric Surgery
Bariatric surgery is a tool to aid in weight loss, but is not a cure. To successfully lose weight and maintain this weight loss, people who have bariatric surgery must commit to healthy eating and regular physical activity for the rest of their lives. Learn more here.
Bariatric Surgery
Learn about bariatric surgery. Many people with obesity can’t simply lose weight with healthy eating and physical activity, despite how hard they may try. Bariatric (obesity) surgery is performed to treat people who have morbid obesity.

Financial Disclosures for J. Michael Gonzalez-Campoy MD, PhD, FACE

EndocrineWeb, a Vertical Health, LLC website, is committed to ensuring that the medical information it presents is accurate, balanced, objective, and trustworthy.

To help achieve this goal, EndocrineWeb requires all authors, editors, and reviewers to disclose any financial relationships or affiliations they have with companies whose products or services may be mentioned in the content they author, edit, or review.

The intent of this policy is to identify any perceived, potential, or real conflicts of interest so that readers can make their own judgments about the value of information being presented.

Author's Statement

I, the undersigned, declare that neither I nor members of my immediate family have a financial interests or affiliation with commercial companies whose products and / or services may be mentioned in the materials I have authored, edited or reviewed for presentation on Vertical Health, LLC’s websites.
There are no disclosures for this author